Estrogens, progestins and lipid metabolism

Maturitas

Volumn 23, Issue SUPPL., 1996, Pages

  Tikkanen, Matti J ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Estrogens; Lipid metabolism; Progestins

Indexed keywords

ESTROGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN LIPASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NANDROLONE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

CHOLESTEROL TRANSPORT; CORONARY ARTERY DISEASE; DIET SUPPLEMENTATION; ENZYME ACTIVITY; ESTROGEN BLOOD LEVEL; GESTAGEN BLOOD LEVEL; HORMONAL REGULATION; HUMAN; LIPID METABOLISM; LIPID TRANSPORT; ORAL DRUG ADMINISTRATION; POSTMENOPAUSE; REVIEW; RISK ASSESSMENT; RISK FACTOR;

EID: 0029744066     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/0378-5122(96)01012-2     Document Type: Article

References (24)

1. Tikkanen MJ. Intravascular lipoprotein remodeling: lipolytic enzymes. In: Fruchart JC, Shepherd J, eds. Human plasma lipoproteins: chemistry, physiology and pathology. Berlin, New York: De Gruyter. Clinical Biochemistry 1989; 3: 143-51.
2. Tikkanen MJ. Role of plasma lipoprotein in the pathogenesis of atheroscelerotic disease, with special reference to sex hormone effects. Am J Obstet Gynecol. 1990; 163: 296-304.
3. Tikkanen MJ, Kuusi T, Nikkilä EA, Sipinen S. Postmenopausal hormone replacement therapy: effects of progestogens on serum lipids and lipoproteins. A review. Maturitas 1986; 8: 7-17.
4. Tikkanen MJ, Kuusi T, Nikkilä EA, Sane T. Very low density lipoprotein triglyceride kinetics during hepatic lipase suppression by estrogen. FEBS Lett. 1985; 181: 160-4.
5. Walsh BW, Schiff I, Rosner B, Greenberg L, Ravnikar V, Sacks FM. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N Engl J Med 1991; 325: 1196-204.
6. Brown MS, Goldstein JL. A receptor-mediated pathway for cholesterol homeostasis. Science 1986; 232: 34-47.
7. Tikkanen NJ, Nikkilä EA, Vartiainen E. Natural oestrogen as an effective tieatment for type-II hyperlipoproteinaemia in postmenopausal women. Lancet 1978; 490-2.
8. Eriksson N, Berglund L, Rudling M, Henriksson P, Angelin B. Effects of estrogen on low density lipoprotein metabolism in males. J Clin Invest 1989; 84: 802-10.
9. Kovanen PT, Brown MS, Goldstein JL. Increased binding of low density lipoprotein to liver membranes from rats treated with 17 alpha-ethinyl estradiol. J Biol Chem 1979; 254: 1367-73.
10. Ma PTS, Yamamoto T, Goldstein JL, Brown MS. Increased mRNA for low density lipoprotein receptor in livers of rabbits treated with 17 alpha ethinyl estradiol. Proc Natl Acad Sci USA 1986; 83: 792-6.
11. Schaefer EJ, Foster DM, Zech LA et al. The effects of estrogen administration on plasma lipoprotein metabolism in premenopausal females. J Clin Endocr Metab 1983; 57: 262-7.
12. Pownall HJ, Gotto AM, Jr. Human plasma Lipoproteins in biology and medicine. In: Rosseau M, ed. Stucture and function of apoliproteins. London: CRC Press Inc., 1992; 1-32.
13. Soma M, Osnago-Gadda I, Paoletti R et al. The lowering of lipoprotein (a) induced by estrogen plus progesterone replacement therapy in postmenopausal women. Arch Intern Med 1993; 153: 1462-8.
14. Farish E, Rolton HA, Barnes JF, Hart DM. Thipoprotein (a) concentrations in postmenopausal women taking norethisterone. Br Med J 1994; 303: 694.
15. Kim CJ, Jang Hc, Cho DH, Min YK. Effects of hormone replacement therapy on lipoprotein(a) and lipids in postmenopausal women. Arterioscler Thromb 1994; 14: 275-81.
16. Tikkanen MJ, Nikkilä EA, Kuusi T, Sipinen S. High density lipoprotein-2 and hepatic lipase: reciprocal changes produced by estrogen and norgestrel. J Clin Endocrinol Metab 1982; 54: 1113-7.
17. Tikkanen MJ, Nikkilä EA. Oral contraceptives and lipoprotein metabolism. J Reprod Med 1986; 31(9): 898-905.
18. 2) and postheparin plasma hepatic lipase activity. Atherosclerosis 1981; 40: 365-9.
19. Walsh BW, Li H, Sacks FM. Effects of postmenopausal hormone replacement with oral and transdermal estrogen on high density lipoprotein metabolism. J Lipid Res 1994; 35: 2083-93.
20. Haffner SM, Kushwaha RS, Foster DM, Applebaum-Bowden D, Hazzard WR. Studies on the metabolic mechanism of reduced density lipoproteins during anabolic steroid therapy. Metabolism 1983; 32: 413-20.
21. Kuusi T, Nikkilä EA, Tikkanen MJ, Sipinen S. Effects of two progestins with different androgenic properties on hepatic endothelial lipase and high density lipoprotein. Atherosclerosis 1985; 54: 251-62.
22. Tikkanen MJ. Combination of estradiol-valerate and cyproterone acetate - a modern regimen for hormone replacement therapy. In: Schneider HPG, Genazzani AR, eds. New Developments in Biosciences 7. Berlin: Walter Gruyter & Co, 1992; 9-15.
23. Bass MK, Newschaffer CJ, Klag MJ, Bush TL. Plasma lipoprotein levels as predictors of cardiovascular death in women. Arch Intern Med 1993; 153: 2209-16.
24. Tikkanen MJ. Mechanisms of cardiovascular protection by postmenopausal hormone replacement therapy. Cardiovasc Risk Factors 1993; 3: 138-43.